home / stock / drio / drio articles
Dario selected to provide integrated approach to improve employee cardiometabolic health - including support for those taking a GLP-1 medication - ...
NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, wil...
Demand for Dario's integrated cardiometabolic solution continues to grow as employers grappling with the surge in GLP-1 medication utilization ...
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholder...
Agreement names Dario as the preferred digital health provider for employer clients NEW YORK, Oct. 5, 2023 /PRNewswire/ -- DarioHealth Corp. (NASD...
News, Short Squeeze, Breakout and More Instantly...
Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes PR Newswire Quasi-randomized study demonstrates the value of Dario's integrated approach to provide one solu...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, has announced that two employers, a national supply chain company and a regional education organization, have selected its integrated chronic condition management solutions. According to the announcement, beginning in the ...
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution PR Newswire Dario selected to provide integrated and proven solutions to improve employee cardiometabolic health NEW YORK , April 18, 2024 /PRNewswire/ -- DarioHealth Corp....